American Association for Cancer Research

Eribulin shows early promise in pediatric sarcoma treatment

The drug eribulin, currently approved for the third-line treatment of breast cancer, may represent a new treatment option for pediatric patients with a type of cancer called sarcoma, according to results of preclinical studies ...

Nov 05, 2013
popularity not rated yet | comments 0

Biomarker may help predict aggressive cancers

For children with central nervous system cancers, the presence of a specific genetic modification—hypermethylation of the TERT promoter—may help predict tumor progression and patient survival, according to results presented ...

Nov 05, 2013
popularity not rated yet | comments 0